Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on UDR, Raises Price Target to $54

Morgan Stanley analyst Richard Hill maintains UDR (NYSE:UDR) with a Equal-Weight and raises the price target from $47 to $54.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Morgan Stanley analyst Richard Hill maintains UDR (NYSE:UDR) with a Equal-Weight and raises the price target from $47 to $54.

U.S. Stocks Turn Higher; Crude Oil Tumbles

By Lisa Levin

Today, 11:39 PM

U.S. stocks turned higher midway through trading, after recording gains in the previous session.

CYAD

Genetron Health And IMPACT Therapeutics Announce Partnership To Drive Development of Synthetic Lethal Product Pipeline

By Benzinga Newsdesk

Today, 11:39 PM

Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer

GTH

Apple, Google At Loggerheads Over NFL Sunday Ticket Deal; Talks May Drag Into Next Year

By Ananya Gairola

Today, 11:39 PM

Apple Inc. (NASDAQ: AAPL) is facing increased competition from Google parent Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) over

AAPL

$100 Invested In T. Rowe Price Gr 20 Years Ago Would Be Worth This Much Today

By Benzinga Insights

Today, 11:39 PM

T. Rowe Price Gr (NASDAQ:TROW) has outperformed the market over the past 20 years by 3.75% on an…

TROW

Morgan Stanley Maintains Equal-Weight on UDR, Raises Price Target to $54

Related Posts

U.S. Stocks Turn Higher; Crude Oil Tumbles

Genetron Health And IMPACT Therapeutics Announce Partnership To Drive Development of Synthetic Lethal Product Pipeline

Apple, Google At Loggerheads Over NFL Sunday Ticket Deal; Talks May Drag Into Next Year

$100 Invested In T. Rowe Price Gr 20 Years Ago Would Be Worth This Much Today